Medibank Private Ltd MDBKY

$31.00 +1.00 (3.33%)

Valuation

Market cap
—
Revenue TTM
$0
Net income TTM
$0
PE ratio
—
Forward PE
—
Profit margin
0.00%
Debt to equity
—

Trading

Volume
800
Avg volume
—
Day's range
$30.70 – $31.00
Shares out
—
Stochastic %K
14%
Beta
—
Analysts
Strong Buy
Price target
—

Price

Company profile

Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optic...

Show more

Medibank Private Limited provides private health insurance in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services comprising dental, optical, and physiotherapy, as well as offers health insurance products to overseas visitors and students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth and primary care services to government and corporate customers; and distributes travel, life, and pet insurance products; It underwrites and distributes private health insurance policies under the Medibank and ahm brands for resident and nonresident customers, broader community with wellbeing, prevention, primary care and homecare, with investments in short stay surgical and mental health facilities. The company was founded in 1976 and is based in Docklands, Australia.

Industry
Insurance - Specialty
Sector
Financial Services
Phone
61 3 8622 5222
Website
https://www.medibank.com.au
Address
695 Collins Street, Level 2, Docklands, Australia

Latest news

No headlines yet.